Reckitt Benckiser Group (OTCMKTS:RBGLY) Coverage Initiated by Analysts at Citigroup

Equities research analysts at Citigroup started coverage on shares of Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a "buy" rating on the stock.

Several other equities research analysts have also recently commented on RBGLY. Barclays raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Monday, December 1st. Jefferies Financial Group reiterated a "hold" rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Morgan Stanley downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research report on Monday, December 15th. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Reckitt Benckiser Group in a report on Monday, October 27th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

Check Out Our Latest Research Report on RBGLY

Reckitt Benckiser Group Trading Down 0.6%

Shares of OTCMKTS RBGLY traded down $0.10 during trading on Wednesday, reaching $16.60. The company had a trading volume of 34,874 shares, compared to its average volume of 229,180. Reckitt Benckiser Group has a 52 week low of $11.75 and a 52 week high of $16.80. The business's 50 day moving average price is $15.92 and its 200-day moving average price is $15.31. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Further Reading

• Five stocks we like better than Reckitt Benckiser Group
• The Crash Has Already Started (Most Just Don’t See It Yet)
• Trump Planning to Use Public Law 63-43: Prepare Now
• “Ominous day” coming to stocks…
• If You Keep Cash In A U.S. Bank Account… Read This NOW
• Punch these codes into your ordinary brokerage account

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here